Winston Pharmaceuticals (Winston Pharmaceuticals) Scaled Net Operating Assets : -0.37 (As of Mar. 2010)

View and export this data going back to 2006. Start your Free Trial

What is Winston Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Winston Pharmaceuticals's operating assets for the quarter that ended in Mar. 2010 was $0.16 Mil. Winston Pharmaceuticals's operating liabilities for the quarter that ended in Mar. 2010 was $0.78 Mil. Winston Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2009 was $1.68 Mil. Therefore, Winston Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2010 was -0.37.

Winston Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for Winston Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winston Pharmaceuticals Scaled Net Operating Assets Chart

Winston Pharmaceuticals Annual Data

Trend

Sep05

Sep06

Sep07

Dec08

Dec09

Scaled Net Operating Assets

-8.25

-46.75

-0.59

-0.19

Winston Pharmaceuticals Quarterly Data
	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10
Scaled Net Operating Assets	Get a 7-Day Free Trial														-0.34	-0.34	-0.40	-0.44	-0.37

Competitive Comparison of Winston Pharmaceuticals's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Winston Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Winston Pharmaceuticals's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Winston Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Winston Pharmaceuticals's Scaled Net Operating Assets falls into.

Winston Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Winston Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2009 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2009 )
=	(Operating Assets (A: Dec. 2009 )	-	Operating Liabilities (A: Dec. 2009 ))	/	Total Assets (A: Dec. 2008 )
=	(0.113	-	1.187)	/	5.791
=	-0.19

where

	Operating Assets		(A: Dec. 2009 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1.676	-	1.563
=	0.113

	Operating Liabilities		(A: Dec. 2009 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.187	-	0	-	0
=	1.187

Winston Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2010 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2010 )
=	(Operating Assets (Q: Mar. 2010 )	-	Operating Liabilities (Q: Mar. 2010 ))	/	Total Assets (Q: Dec. 2009 )
=	(0.164	-	0.777)	/	1.676
=	-0.37

where

	Operating Assets		(Q: Mar. 2010 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.842	-	0.678
=	0.164

	Operating Liabilities		(Q: Mar. 2010 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.777	-	0	-	0
=	0.777

Winston Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Winston Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Winston Pharmaceuticals (Winston Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Winston Pharmaceuticals Inc (GREY:WPHM) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 North Fairway Drive, Suite 134, Vernon Hills, IL, USA, 60061

Website

http://www.winstonlabs.com

Winston Pharmaceuticals Inc is a pharmaceutical company, which is engaged in the discovery and development of products for pain management. The company focuses on major pain indications such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo- and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease.

Executives

Frost Phillip Md Et Al	10 percent owner	4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Frost Gamma Investments Trust	10 percent owner	4400 BISCAYNE BLVD, MIAMI FL 33137
Subbarao V Uppaluri	director	4400 BISCAYNE BOULEVARD, SUITE 1500, MIAMI FL 33137
Curtis Lockshin	director	4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Glenn L Halpryn	director	4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Steven Jerry Glauser	10 percent owner	1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131
Noah M Silver	director, officer: Vice President	4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Alan Jay Weisberg	director, officer: Chief Financial Officer	2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Stephen Bittel	10 percent owner	4400 BISCAYNE BOULEVARD SUITE 950 MIAMI FL 33137

Winston Pharmaceuticals (Winston Pharmaceuticals) Headlines

No Headlines